Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.54 - $6.84 $165,802 - $320,365
46,837 New
46,837 $288,000
Q3 2023

Nov 13, 2023

SELL
$3.56 - $5.75 $103,884 - $167,790
-29,181 Reduced 47.48%
32,280 $185,000
Q2 2023

Aug 14, 2023

BUY
$3.51 - $4.69 $215,728 - $288,252
61,461 New
61,461 $223,000
Q3 2022

Nov 14, 2022

BUY
$2.37 - $4.28 $42 - $77
18 Added 0.16%
11,335 $41,000
Q2 2022

Aug 15, 2022

BUY
$1.23 - $3.25 $13,919 - $36,780
11,317 New
11,317 $37,000
Q1 2022

May 13, 2022

SELL
$2.0 - $3.28 $31,306 - $51,341
-15,653 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$3.14 - $5.15 $49,150 - $80,612
15,653 New
15,653 $49,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $720M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.